Clinical Trials
7
Active:3
Completed:3
Trial Phases
2 Phases
Phase 1:4
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (66.7%)Phase 2
2 (33.3%)Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer
Phase 2
Completed
- Conditions
- Ovarian CancerCancer
- Interventions
- Drug: CPC634 (CriPec® docetaxel)
- First Posted Date
- 2018-11-15
- Last Posted Date
- 2020-12-28
- Lead Sponsor
- Cristal Therapeutics
- Target Recruit Count
- 25
- Registration Number
- NCT03742713
- Locations
- 🇧🇪
Universitaire Ziekenhuizen Leuven, Leuven, Belgium
🇧🇪CHU de Liège, Liège, Belgium
🇳🇱University Medical Center Groningen, Groningen, Netherlands
A Study of CriPec® Docetaxel Given to Patients With Solid Tumours
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2018-09-24
- Lead Sponsor
- Cristal Therapeutics
- Target Recruit Count
- 33
- Registration Number
- NCT02442531
- Locations
- 🇧🇪
University Hospital Leuven, Leuven, Belgium
🇳🇱VUMC Amsterdam, Amsterdam, Netherlands
🇳🇱UMC Groningen, Groningen, Netherlands
News
No news found